These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27386761)

  • 1. Zero-valent Fe confined mesoporous silica nanocarriers (Fe(0) @ MCM-41) for targeting experimental orthotopic glioma in rats.
    Shevtsov MA; Parr MA; Ryzhov VA; Zemtsova EG; Arbenin AY; Ponomareva AN; Smirnov VM; Multhoff G
    Sci Rep; 2016 Jul; 6():29247. PubMed ID: 27386761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
    Thiyagarajan V; Lin SX; Lee CH; Weng CF
    Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
    Mo J; He L; Ma B; Chen T
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
    Liu Q; Zhang J; Xia W; Gu H
    Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
    Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
    Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
    Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
    Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.
    Lu J; Liong M; Li Z; Zink JI; Tamanoi F
    Small; 2010 Aug; 6(16):1794-805. PubMed ID: 20623530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.
    Quan G; Pan X; Wang Z; Wu Q; Li G; Dian L; Chen B; Wu C
    J Nanobiotechnology; 2015 Feb; 13():7. PubMed ID: 25643602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-Term Oral Administration of Mesoporous Silica Nanoparticles Potentially Induced Colon Inflammation in Rats Through Alteration of Gut Microbiota.
    Yu Y; Wang Z; Wang R; Jin J; Zhu YZ
    Int J Nanomedicine; 2021; 16():881-893. PubMed ID: 33574668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
    Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier.
    Baghirov H; Karaman D; Viitala T; Duchanoy A; Lou YR; Mamaeva V; Pryazhnikov E; Khiroug L; de Lange Davies C; Sahlgren C; Rosenholm JM
    PLoS One; 2016; 11(8):e0160705. PubMed ID: 27547955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
    Saroj S; Rajput SJ
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1115-S1130. PubMed ID: 30669865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution.
    Baeza A; Manzano M; Colilla M; Vallet-Regí M
    Biomater Sci; 2016 May; 4(5):803-13. PubMed ID: 26902682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
    Cui Y; Dong H; Cai X; Wang D; Li Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
    Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
    Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.